Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong
· Delayed Price · Currency is HKD 54.30
-0.50 (-0.91%)
Apr 29, 2026, 4:08 PM HKT
HKG:6609 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 408.29 | 277.9 | 232.34 | 183.03 | 90.09 | Upgrade
|
| Revenue Growth (YoY) | 46.92% | 19.61% | 26.94% | 103.17% | 518.66% | Upgrade
|
| Cost of Revenue | 136.12 | 104.24 | 80.55 | 59.15 | 35.14 | Upgrade
|
| Gross Profit | 272.17 | 173.66 | 151.79 | 123.88 | 54.95 | Upgrade
|
| Selling, General & Admin | 187.12 | 137.81 | 153.88 | 167.99 | 135.01 | Upgrade
|
| Research & Development | 40.76 | 58.94 | 123.83 | 153.69 | 76.31 | Upgrade
|
| Other Operating Expenses | 6.22 | 10.26 | 0.95 | 1.82 | 3.21 | Upgrade
|
| Operating Expenses | 234.1 | 207 | 278.66 | 323.5 | 214.53 | Upgrade
|
| Operating Income | 38.07 | -33.34 | -126.87 | -199.62 | -159.58 | Upgrade
|
| Interest Expense | -2.06 | -1.75 | -2.16 | -2.15 | -2.36 | Upgrade
|
| Interest & Investment Income | 6.24 | 8.77 | 11.2 | 15.14 | 5.5 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -34.8 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.17 | 1.4 | 8.3 | -22.28 | Upgrade
|
| Other Non Operating Income (Expenses) | 16.17 | 8.79 | 11.21 | 11.88 | -23.02 | Upgrade
|
| EBT Excluding Unusual Items | 58.42 | -16.36 | -105.22 | -201.25 | -201.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | 27.26 | 4.37 | 0.93 | - | 3.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.73 | - | 1.37 | - | - | Upgrade
|
| Pretax Income | 86.41 | -11.99 | -102.92 | -201.25 | -197.91 | Upgrade
|
| Income Tax Expense | 3.07 | 1.63 | -8.91 | -0.87 | - | Upgrade
|
| Earnings From Continuing Operations | 83.34 | -13.62 | -94.01 | -200.38 | -197.91 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 3.68 | Upgrade
|
| Net Income | 83.34 | -13.62 | -94.01 | -200.38 | -194.23 | Upgrade
|
| Net Income to Common | 83.34 | -13.62 | -94.01 | -200.38 | -194.23 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 38 | 38 | 38 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 38 | 38 | 33 | Upgrade
|
| Shares Change (YoY) | 0.47% | -0.81% | -0.51% | 14.60% | 52.84% | Upgrade
|
| EPS (Basic) | 2.21 | -0.36 | -2.47 | -5.24 | -5.82 | Upgrade
|
| EPS (Diluted) | 2.20 | -0.36 | -2.47 | -5.24 | -5.82 | Upgrade
|
| Free Cash Flow | - | -7.27 | -92.98 | -303.28 | -258.69 | Upgrade
|
| Free Cash Flow Per Share | - | -0.19 | -2.44 | -7.92 | -7.75 | Upgrade
|
| Gross Margin | 66.66% | 62.49% | 65.33% | 67.68% | 60.99% | Upgrade
|
| Operating Margin | 9.32% | -12.00% | -54.60% | -109.06% | -177.13% | Upgrade
|
| Profit Margin | 20.41% | -4.90% | -40.46% | -109.48% | -215.59% | Upgrade
|
| Free Cash Flow Margin | - | -2.62% | -40.02% | -165.70% | -287.14% | Upgrade
|
| EBITDA | 61.54 | -9.87 | -102.57 | -173.68 | -152.15 | Upgrade
|
| EBITDA Margin | 15.07% | -3.55% | -44.14% | -94.89% | -168.88% | Upgrade
|
| D&A For EBITDA | 23.47 | 23.47 | 24.3 | 25.94 | 7.43 | Upgrade
|
| EBIT | 38.07 | -33.34 | -126.87 | -199.62 | -159.58 | Upgrade
|
| EBIT Margin | 9.32% | -12.00% | -54.60% | -109.06% | -177.13% | Upgrade
|
| Effective Tax Rate | 3.56% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.